Bladder Cancer Therapeutics and Diagnostics Industry Overview
The bladder cancer and therapeutics and diagnostics market is moderately competitive and consists of several major players. The major companies active in the market are AstraZeneca, Bristol-Myers Squibb Company, Eli Lilly, GlaxoSmithKline, F. Hoffmann-La Roche Ltd, Novartis, and Pfizer. The companies present in the market are focusing on product innovations, expansions, finding new markets, or innovating their core competencies, in order to expand their market shares.
Bladder Cancer Therapeutics and Diagnostics Market Leaders
-
Bristol-Myers Squibb Company
-
GlaxoSmithKline PLC
-
Johnson & Johnson (Janssen Pharmaceutical)
-
F. Hoffmann-La Roche
-
Merck & Co. Inc.
- *Disclaimer: Major Players sorted in no particular order
